Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-13

FDA Approved: TERIFLUNOMIDE — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved the original ANDA for teriflunomide from Biocon Pharma Inc., authorizing a generic version of the multiple sclerosis therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

ORIG AP for TERIFLUNOMIDE (TERIFLUNOMIDE)